ArticleBMC public health2019
Implementation of the World's largest measles-rubella mass vaccination campaign in Bangladesh: a process evaluation.
Article in BMC public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- The effect of supporting districts to operationalise digital payments for vaccination campaign workers: a cluster randomised controlled trial during the 2022 polio vaccination campaign in Uganda.BMJ global health · 2025Trial
- Lessons for Immunisation Policy and Practice From the Deadly Measles Resurgence in Bangladesh.Tropical medicine & international health : TM & IH · 2026Article
- Community-level COVID-19 vaccination promotion capacity and its association with vaccination dose per capita in China: an entropy-weighted TOPSIS and multilevel analysis.BMC public health · 2026Article
- Article
- Integrated people-centered eye care: A scoping review on engaging communities in eye care in low- and middle-income settings.PloS one · 2023Article
- Article
- Partnerships in the introduction of new routine vaccines in Bangladesh: evidence from a prospective process evaluation.BMJ open · 2022Review
- Prevalence of measles antibodies among migrant workers in Singapore: a serological study to identify susceptible population subgroups.BMC infectious diseases · 2022Article
- Considerations for Establishing Successful Coronavirus Disease Vaccination Programs in Africa.Emerging infectious diseases · 2021Review
- Challenges and Opportunities of Mass Vaccination Centers in COVID-19 Times: A Rapid Review of Literature.Vaccines · 2021Review
- Use of concurrent evaluation to improve implementation of a home fortification programme in Bangladesh: a methodological innovation.Public health nutrition · 2021Article
- Every Dog Has Its Data: Evaluation of a Technology-Aided Canine Rabies Vaccination Campaign to Implement a Microplanning Approach.Frontiers in public health · 2021Article
- Preparing the Community for a Vaccine Against COVID-19.Oman medical journal · 2020Article
- Reviewing Solutions of Scale for Canine Rabies Elimination in India.Tropical medicine and infectious disease · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundGavi, the Vaccine Alliance, supported a mass vaccination Measles-Rubella Campaign (MRC) in Bangladesh during January-February 2014.
methodsWe conducted a mixed-method process evaluation to understand the successes and challenges in implementation of the MRC. We reviewed documents for the MRC and the immunization programme in Bangladesh; observed meetings, vaccination sessions, and health facilities; and conducted 58 key informant interviews, 574 exit interviews with caregivers and 156 brief surveys with stakeholders involved in immunization. Our theory of Change for vaccination delivery guided our assessment of ideal implementation milestones and indicators to compare with the actual implementation processes.
resultsWe identified challenges relating to country-wide political unrest, administrative and budgetary delays, shortage of transportation, problems in registration of target populations, and fears about safety of the vaccine. Despite these issues, a number of elements contributed to the successful launch of the MRC. These included: the comprehensive design of the campaign; strong partnerships between immunization authorities in the government system, Alliance partners, and civil society actors; and motivated and skilled health workers at different levels of the health system.
conclusionsThe successful implementation of the MRC in spite of numerous contextual and operational challenges demonstrated the adaptive capacity of the national immunization programme and its partners that has positive implications for future introductions of Gavi-supported vaccines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.